デフォルト表紙
市場調査レポート
商品コード
1551540

小児用医薬品の世界市場

Pediatric Medicines

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 387 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.63円
小児用医薬品の世界市場
出版日: 2024年09月10日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 387 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

小児用医薬品の世界市場は2030年までに1,790億米ドルに達する見込み

2023年に1,167億米ドルと推定された小児用医薬品の世界市場は、2030年には1,790億米ドルに達し、分析期間2023-2030年のCAGRは6.3%で成長すると予測されます。本レポートで分析したセグメントの1つである呼吸器疾患治療薬は、CAGR 7.5%を記録し、分析期間終了時には687億米ドルに達すると予測されます。自己免疫疾患治療薬セグメントは、分析期間中のCAGRが6.3%と推定されます。

米国市場は318億米ドルと推定、中国はCAGR 10.3%で成長すると予測

米国の小児用医薬品市場は2023年に318億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに390億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは10.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と6.4%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の小児用医薬品市場- 主要動向と促進要因のまとめ

小児用医薬品はどのように小児ヘルスケアに革命を起こしているのか?

小児用医薬品は、乳幼児、小児、青少年特有のニーズに合わせた治療を提供することで、小児ヘルスケアに革命を起こしています。大人の薬とは異なり、小児用医薬品は子供の発達中の体を注意深く考慮して処方され、適切な投与量、処方、投与方法を保証します。小児は単なる「小さな大人」ではなく、体内での薬物処理が異なるため、成長、臓器の発達、代謝速度を考慮した独自の製剤が必要となるため、このような専門性は極めて重要です。小児に特化した医薬品が利用できるようになったことで、耳の感染症や喘息といった一般的な小児疾患から、若年性糖尿病や先天性心疾患といった複雑で慢性的な疾患まで、幅広い疾患の管理が大幅に改善されました。小児用医薬品は、安全で効果的、かつ年齢に応じた治療を提供することで、子どもたちのヘルスケアの質を高め、副作用を減らし、乳幼児期から思春期までより良い健康結果を保証しています。

どのようなイノベーションが小児用医薬品の機能を高めていますか?

小児用医薬品のイノベーションは、ドラッグフォーミュレーション、デリバリーシステム、個別化医療の進歩を通じて機能性を高めています。最も重要な開発の1つは、液状懸濁液、溶解可能な錠剤、風味をつけたシロップ剤など、子供が薬を服用しやすい製剤の開発です。これらの製剤は、特に錠剤を飲み込むのが困難であったり、味に敏感であったりする幼児にとって、治療レジメンを確実に守るために極めて重要です。さらに、経皮パッチや吸入器などの新しいドラッグデリバリーシステムは、投与が容易で従来の方法に伴うストレスを軽減する非侵襲的な代替手段を提供します。個別化医療は小児科領域でも進展しており、遺伝子検査やバイオマーカーの同定により、個々の子どもの遺伝子プロファイルに合わせた治療が可能になり、より効果的で安全な治療が保証されます。さらに、薬理ゲノミクスの進歩により、子どもたちが特定の薬にどのように反応するかを予測することができるようになり、ヘルスケアプロバイダーは治療計画を最適化できるようになっています。このような技術革新により、小児用医薬品はより利用しやすく、効果的で、子供特有のニーズに沿ったものとなり、より的確で成功するヘルスケア介入への道を開いています。

小児用医薬品は子供の健康結果や家族の幸福にどのような影響を与えますか?

小児用医薬品は、病気の負担を軽減し、子供とその家族の生活の質を向上させる効果的な治療を提供することで、子供の健康結果と家族の幸福に大きな影響を与えます。これらの医薬品は、子ども特有の医療ニーズに対応することで、病気をより効果的に予防・管理し、入院や緊急医療、長期的な健康合併症の頻度や重症度を軽減します。このような健康状態の改善により、子どもたちは、身体的、情緒的、社会的な発達に不可欠な、学校や遊びなどの日常的な活動に、より十分に参加できるようになります。家族にとっては、安全で効果的な小児用医薬品が利用できることで、子どもの病気の管理に伴うストレスや不安が軽減され、子どもが適切な治療を受けているという安心感が得られます。さらに、小児科の治療がうまく設計されていれば、頻繁な受診や複雑な医療レジメンの必要性が減り、治療が簡素化され、家族がより正常で安定した日常生活を維持できるようになります。全体として、小児用医薬品は、子どもたちの健康と幸福を支え、より健康的な次世代を育み、病気の子どもたちの世話をする家族が直面する課題を緩和する上で極めて重要です。

小児用医薬品市場の成長を促進する動向は?

小児用医薬品市場の成長を後押ししているのは、個別化医療への注目の高まり、小児の慢性疾患の増加、安全性と規制要件の重視の高まりなど、いくつかの動向です。特に、個別化医療へのシフトは、個々の小児の遺伝的・生物学的特徴に合わせた治療法の開発を可能にし、有効性を向上させ、副作用のリスクを低減させるため、大きなインパクトがあります。小児における喘息、肥満、糖尿病などの慢性疾患の増加も、これらの疾患を長期にわたって管理し、子どもが病気にもかかわらず健康的な生活を送れるようにする専門的な薬剤への需要を促進しています。さらに、安全性と小児用医薬品に関する規制要件が重視されるようになり、製薬会社は小児特有のニーズに対応するための厳密な試験や製剤調整に投資するようになっています。FDAやEMAなどの規制機関は、小児に特化した医薬品の開発を奨励するガイドラインを制定し、新しい治療が幼い患者にとって安全かつ有効であることを保証しています。こうした動向は、ヘルスケアにおける小児医療の重要性がますます認識されつつあることを浮き彫りにしており、この重要な分野における継続的な拡大と技術革新が、子ども特有のニーズを可能な限り最良の治療で満たすことを確実にすることを強調しています。

調査対象企業の例(全51件)

  • AbbVie Inc.
  • AstraZeneca PLC
  • BioMarin Pharmaceutical Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Cipla Limited
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Helsinn Healthcare SA
  • Heron Therapeutics, Inc.
  • Jazz Pharmaceuticals plc
  • Novartis AG
  • Pfizer Inc.
  • PTC Therapeutics, Inc.
  • Sanofi SA
  • Sumitomo Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24627

Global Pediatric Medicines Market to Reach US$179.0 Billion by 2030

The global market for Pediatric Medicines estimated at US$116.7 Billion in the year 2023, is expected to reach US$179.0 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Respiratory Disorder Drugs, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$68.7 Billion by the end of the analysis period. Growth in the Autoimmune Disorder Drugs segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.8 Billion While China is Forecast to Grow at 10.3% CAGR

The Pediatric Medicines market in the U.S. is estimated at US$31.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$39.0 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Pediatric Medicines Market - Key Trends and Drivers Summarized

How Are Pediatric Medicines Revolutionizing Child Healthcare?

Pediatric medicines are revolutionizing child healthcare by providing tailored treatments that meet the specific needs of infants, children, and adolescents. Unlike adult medications, pediatric medicines are formulated with careful consideration of a child’s developing body, ensuring appropriate dosages, formulations, and administration methods. This specialization is crucial because children are not simply "small adults"; their bodies process drugs differently, requiring unique formulations that consider their growth, organ development, and metabolic rates. The availability of pediatric-specific medicines has significantly improved the management of a wide range of conditions, from common childhood illnesses like ear infections and asthma to more complex and chronic conditions such as juvenile diabetes and congenital heart defects. By providing safe, effective, and age-appropriate treatments, pediatric medicines are enhancing the quality of healthcare for children, reducing adverse drug reactions, and ensuring better health outcomes from infancy through adolescence.

What Innovations Are Enhancing the Functionality of Pediatric Medicines?

Innovations in pediatric medicines are enhancing functionality through advancements in drug formulations, delivery systems, and personalized medicine. One of the most significant developments is the creation of child-friendly formulations, such as liquid suspensions, dissolvable tablets, and flavored syrups, which make it easier for children to take their medications. These formulations are crucial for ensuring adherence to treatment regimens, especially for young children who may have difficulty swallowing pills or are sensitive to taste. Additionally, novel drug delivery systems, such as transdermal patches and inhalers, offer non-invasive alternatives that are easier to administer and reduce the stress associated with traditional methods. Personalized medicine is also making strides in pediatrics, with genetic testing and biomarker identification allowing for treatments that are tailored to the individual child’s genetic profile, ensuring more effective and safer therapies. Furthermore, advancements in pharmacogenomics are helping to predict how children will respond to specific medications, enabling healthcare providers to optimize treatment plans. These innovations are making pediatric medicines more accessible, effective, and aligned with the unique needs of children, paving the way for more precise and successful healthcare interventions.

How Do Pediatric Medicines Impact Child Health Outcomes and Family Well-being?

Pediatric medicines have a profound impact on child health outcomes and family well-being by providing effective treatments that reduce the burden of illness and improve the quality of life for both children and their families. By addressing the specific medical needs of children, these medicines help prevent and manage illnesses more effectively, reducing the frequency and severity of hospitalizations, medical emergencies, and long-term health complications. This improvement in health outcomes allows children to engage more fully in everyday activities, including school and play, which are essential for their physical, emotional, and social development. For families, the availability of safe and effective pediatric medicines alleviates the stress and anxiety associated with managing a child’s illness, providing peace of mind that their child is receiving appropriate care. Additionally, well-designed pediatric treatments can reduce the need for frequent doctor visits and complicated medical regimens, simplifying care and allowing families to maintain a more normal and stable routine. Overall, pediatric medicines are crucial in supporting the health and well-being of children, fostering a healthier future generation, and easing the challenges faced by families caring for sick children.

What Trends Are Driving Growth in the Pediatric Medicines Market?

Several trends are driving growth in the pediatric medicines market, including the increasing focus on personalized medicine, the rise of chronic diseases in children, and the growing emphasis on safety and regulatory requirements. The shift towards personalized medicine is particularly impactful, as it allows for the development of treatments that are tailored to the genetic and biological characteristics of individual children, improving efficacy and reducing the risk of adverse effects. The rise of chronic conditions such as asthma, obesity, and diabetes in children is also fueling demand for specialized medications that can manage these conditions over the long term, ensuring that children can lead healthier lives despite their illnesses. Additionally, there is a growing emphasis on safety and the regulatory requirements for pediatric medicines, which is driving pharmaceutical companies to invest in rigorous testing and formulation adjustments to meet the specific needs of children. Regulatory bodies like the FDA and EMA have established guidelines that encourage the development of pediatric-specific drugs, ensuring that new treatments are both safe and effective for young patients. These trends highlight the increasing recognition of the importance of pediatric medicine in healthcare and underscore the continued expansion and innovation in this critical area, ensuring that the unique needs of children are met with the best possible treatments.

Select Competitors (Total 51 Featured) -

  • AbbVie Inc.
  • AstraZeneca PLC
  • BioMarin Pharmaceutical Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Cipla Limited
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Helsinn Healthcare SA
  • Heron Therapeutics, Inc.
  • Jazz Pharmaceuticals plc
  • Novartis AG
  • Pfizer Inc.
  • PTC Therapeutics, Inc.
  • Sanofi SA
  • Sumitomo Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Pediatric Medicines - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Focus on Pediatric Health Boosts Development of Specialized Medicines
    • Rising Incidence of Chronic Diseases Among Children Driving Demand for Advanced Treatments
    • Expansion of Vaccine Programs and Their Impact on Pediatric Health
    • Technological Advances in Pediatric Diagnostic Tools
    • R&D Focus on Addressing Unmet Medical Needs in Pediatric Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pediatric Medicines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pediatric Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Respiratory Disorder Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Respiratory Disorder Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Respiratory Disorder Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Autoimmune Disorder Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Autoimmune Disorder Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Autoimmune Disorder Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Gastrointestinal Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Gastrointestinal Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Gastrointestinal Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Drug Class by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Drug Class by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Topical Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • JAPAN
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • CHINA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • EUROPE
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Pediatric Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • FRANCE
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • GERMANY
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Pediatric Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • INDIA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Pediatric Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Pediatric Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Pediatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030
  • AFRICA
    • Pediatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Pediatric Medicines by Drug Class - Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Pediatric Medicines by Drug Class - Percentage Breakdown of Value Sales for Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs and Other Drug Class for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Pediatric Medicines by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Pediatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Pediatric Medicines by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Pediatric Medicines by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2024 & 2030

IV. COMPETITION